Overview
Thank you for your interest in working with Terumo Blood and Cell Technologies External Research Program (ERP). Terumo Blood and Cell Technologies is committed to the advancement of healthcare worldwide by supporting studies in relevant research areas of interest, developed and sponsored by independent investigators or non-commercial sponsors around the globe. An investigator-initiated study (IIS) may be a clinical or nonclinical study conducted without the participation of Terumo Blood and Cell Technologies.
All submissions will be reviewed based on scientific merit, patient or donor safety, strategic alignment, degree of new scientific and clinical evidence, and fair market value. Terumo Blood and Cell Technologies receives many requests for support of research studies. While all submissions will be evaluated, not all submissions can be supported.
For an IIS, the researcher functions both as the sponsor and investigator for the study and is responsible for study conception, design and operational execution; data handling, analysis and interpretation; subsequent reporting and publication; and compliance with all local laws and regulations.
Initial Proposal Application
-
Required supporting documents in English
-
Principal investigator’s curriculum vitae
-
Project summary to include:
- Background
- Objective and rationale
- Primary endpoints
- Project duration
- Requested support
- Materials (e.g., disposable sets/kits)
- Equipment loans
- Monetary (in U.S. dollars)